Getein Biotech, Inc (SHA:603387)

Getein Biotech Revenue

Getein Biotech had revenue of 267.50M CNY in the quarter ending March 31, 2026, with 9.57% growth. This brings the company's revenue in the last twelve months to 1.08B, down -1.13% year-over-year. In the year 2025, Getein Biotech had annual revenue of 1.05B, down -9.71%.

• Revenue (ttm): 1.08B
• Revenue Growth: -1.13%
• P/S Ratio: 4.29
• Revenue / Employee: 552.17K
• Employees: 1,947
• Market Cap: 4.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.05B	-113.08M	-9.71%
Dec 31, 2024	1.16B	-204.36M	-14.93%
Dec 31, 2023	1.37B	-452.70M	-24.85%
Dec 31, 2022	1.82B	420.16M	29.97%
Dec 31, 2021	1.40B	278.37M	24.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error